Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. - Wikidata - awgldk - TriplyDB

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

http://www.wikidata.org/entity/Q46704866

about

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients Phosphate binders for preventing and treating bone disease in chronic kidney disease patients Chronic kidney disease mineral and bone disorder in children Pre-treatment considerations in childhood hypertension due to chronic kidney disease Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations The health benefits of vitamin K The role of phosphorus in the development and progression of vascular calcification Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline Phosphate control in dialysis Calcium and phosphate impact cardiovascular risk.Vascular calcification: When should we interfere in chronic kidney disease patients and how?Hyperphosphatemia. The hidden killer in chronic kidney disease Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of Cardiology Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study.Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.Pharmacotherapy of end-stage renal disease.Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.Phosphate and cardiovascular disease Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients.Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D Calcium balance and negative impact of calcium load in peritoneal dialysis patients.Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability Chronic kidney disease: mineral and bone disorder in children.Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study.Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.Vascular calcification on plain radiographs is associated with carotid intima media thickness, malnutrition and cardiovascular events in dialysis patients: a prospective observational study.Evaluating the effects of sevelamer carbonate on cardiovascular structure and function in chronic renal impairment in Birmingham: the CRIB-PHOS randomised controlled trial.Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial.Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications.Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy.

P2860

Q24234036-38156C3D-6E7F-4334-AA7A-6E09D2514B88 Q24244049-DCBC5D5A-3D91-48E3-9BCA-12BA86F659D9 Q24642788-38B01327-B0CD-4579-985A-88DF863B22CC Q26777613-AF1BDBD3-754F-4C5D-B01A-4C23B6A4B3CE Q26781361-ECC6693A-E675-46DA-B652-258988DAD603 Q26782816-76C22A78-BEE6-41D6-AC3E-0199AEC1B97E Q26823897-C9C86DFC-5738-48B8-92A1-9AAE20B71557 Q26830013-268A822F-7EAE-45A4-AA7E-9B8B08ED9B65 Q26849298-64AC4E96-F28A-4211-8C38-50715B62E855 Q26866391-BBBB84A5-C199-48EB-A4B1-FAEB790E7F7F Q27025339-0DDC843A-299A-4B2E-8CA8-EFB6EBD5073E Q27687570-A5672CB2-3856-4887-A9BC-1A4E8F87A737 Q28071582-274C695D-A23E-4855-B0F7-3423C26A65B1 Q28081229-1C820F4B-02BA-4244-AE19-B5E1CBC2B2DD Q30277401-445BDBB1-9EF6-429D-B940-166A87F9037E Q30433029-434F9A5A-B0D0-40D1-A2AA-CC39DDEAE83D Q30473207-B126F810-7441-40F3-A0A0-CB4E630E5019 Q31038421-4B025534-2D52-41C0-BBCA-79531DECEFAE Q33531889-239F60A1-5A13-4B40-BC78-241942D21AC2 Q33562017-8E576D04-5FA5-4142-B7C1-98A01A1C4A8C Q33562186-C0DC11E8-FA43-46E1-B8B8-05A5E2B65B2E Q33566596-7A0248F8-2004-4F3B-AD7E-FE0E06E4DAC3 Q33610457-D36415A6-D483-4B22-A920-D5894E646399 Q33611410-43BC3975-38D5-473B-B2FB-475443CCCAD6 Q33615078-982E4A0C-B95D-4D49-92F9-24FFFD342259 Q33770086-278616E7-A1AA-4A9D-8802-D249F33ECBFC Q33801022-42A82C22-8F96-4AF8-841F-B4E692E90DEC Q33837633-CBD7D117-2519-4534-8A8E-E4B90B08665F Q33840398-19F6FDCD-46B3-41D4-92E9-852F6A5F6722 Q34037021-D2A21672-2FDE-4D2A-9C30-A404330EC239 Q34213692-E5304966-257D-451E-8E59-C7C4756D2740 Q34402661-9877A828-E6C9-419B-A493-F056AF15489B Q34497204-F92F82A7-F686-44E3-8505-FDFA03043F13 Q34505136-D2C8A3F1-2934-401F-9BD2-C0BB13C31456 Q34566734-399AE413-B467-4396-8346-DA3C9E4542D9 Q34576615-1CC1D49E-CA93-4BA6-A296-8E8E007830CD Q34576693-A397C322-8CFA-4863-B050-A8D4CD2F1E87 Q34587149-F523C794-1FD5-4184-AA39-3339A1457132 Q34669852-476DE104-966B-422E-A28C-8E4039BFAC58 Q34724266-F26F8F5B-1D72-4E70-8E1E-BEFCECF10B82

P2860

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

http://www.wikidata.org/entity/Q46704866

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Effects of sevelamer and calci ...... patients new to hemodialysis.

@en

Effects of sevelamer and calci ...... patients new to hemodialysis.

@nl

type

label

Effects of sevelamer and calci ...... patients new to hemodialysis.

@en

Effects of sevelamer and calci ...... patients new to hemodialysis.

@nl

prefLabel

Effects of sevelamer and calci ...... patients new to hemodialysis.

@en

Effects of sevelamer and calci ...... patients new to hemodialysis.

@nl

P1433

Q46704866-D9C41628-4344-479F-A4EF-2FC2F26AD2C1

P1476

Q46704866-D59C28DC-104B-426D-B254-AE9D59808CBB

P2093

Q46704866-2EC5B14D-4EC8-4229-AF01-BF7DE0307AC3

Q46704866-3CAE8C62-CAC7-4233-9D6D-C17FE991A3C1

Q46704866-7F0430C2-E6A3-4DF9-80B7-8471AF97F2D2

Q46704866-BC3B4885-8DAC-442A-A4F2-464AC3A0824E

Q46704866-C6F1D3B5-9138-4D42-8EFC-93023E854DA1

Q46704866-C9302D67-9F9B-44DF-8367-24B3A1B6F474

Q46704866-E5FE4821-F5A7-4790-BC40-52671EE33E7D

P2888

Q46704866-113EA67D-6303-45AE-85D5-38B000FCF550

P304

Q46704866-0ECFBF12-D485-4301-809D-AD5EF0384296

P31

Q46704866-C4472928-00FA-4A89-87D0-2F183FE12B46

P356

Q46704866-C3FB38E0-2595-49AE-AC08-29BA9B1B40EA

P407

Q46704866-788D1F9A-F9DF-4BE2-B3F2-31F311580629

P433

Q46704866-ADE6ACAA-03E3-4208-9B8C-D7810504CB3B

P478

Q46704866-7CA3C6F4-4291-4484-A697-E0D2BF9B36C5

P577

Q46704866-B28603AD-9952-43F7-A303-A2A6FA54EEBD

P5875

Q46704866-0C929663-6137-47C6-9537-80254840133A

P6179

Q46704866-FD1C0B65-1FF6-4AF5-BB8D-36BCDE0A2EEC

P698

Q46704866-DC2D19D0-B09F-4719-86BB-4BCF0E58D0B9

P921

Q46704866-6F8DBB6C-424B-456D-AE70-7ADD9BEAF904

P356

J.1523-1755.2005.00600.X

P1433

Kidney International

P1476

Effects of sevelamer and calci ...... patients new to hemodialysis.

@en

P2093

Albert Dreisbach

http://www.w3.org/2001/XMLSchema#string

David M Spiegel

http://www.w3.org/2001/XMLSchema#string

Geoffrey A Block

http://www.w3.org/2001/XMLSchema#string

James Ehrlich

http://www.w3.org/2001/XMLSchema#string

Jill Lindbergh

http://www.w3.org/2001/XMLSchema#string

Paolo Raggi

http://www.w3.org/2001/XMLSchema#string

Ravindra Mehta

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2005.00600.x

P304

1815-1824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1523-1755.2005.00600.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7597798

http://www.w3.org/2001/XMLSchema#string

P6179

1012436727

http://www.w3.org/2001/XMLSchema#string

P698

16164659

http://www.w3.org/2001/XMLSchema#string

P921